MUC1 and idiopathic pulmonary fibrosis: In our recent (involving nintedanib-treated patients with IPF, [43]) and present (involving a distinct cohort of pirfenidone-treated patients with IPF) studies, we showed that blood mucin-1 levels at baseline alone can already be prognostic.